Ami Organics Limited

AMIORG

INE00FF01017

Diversified Chemicals

Market Closed - NSE India S.E. Other stock markets 07:43:46 2024-04-26 am EDT			5-day change	1st Jan Change
1,214 ^INR	-0.67%		+0.74%	+8.21%

Apr. 15	Ami Organics Gets Board Nod to Raise Up To INR5 Billion Via QIP	MT
Feb. 12	Transcript : Ami Organics Limited, Q3 2024 Earnings Call, Feb 12, 2024

Ami Organics Limited has filed an IPO.

June 04, 2021 at 12:00 am EDT

Ami Organics Limited has filed an IPO. Security Name: Equity Shares Security Type: Common Stock Transaction Features: Regulation S

Latest news about Ami Organics Limited

Ami Organics Gets Board Nod to Raise Up To INR5 Billion Via QIP	Apr. 15	MT
Transcript : Ami Organics Limited, Q3 2024 Earnings Call, Feb 12, 2024	Feb. 12
Ami Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
Ami Organics Unit Begins Commercial Operations of Lithium-Ion Battery Cell Production	Jan. 28	MT
Ami Organics Signs MoU to Manufacture Battery Cell Electrolytes in Gujarat, India	Dec. 21	MT
Ami Organics to Manufacture Two APIs for Orion Subsidiary	Dec. 14	MT
Ami Organics Limited and Fermion Ink Another Agreement for Two Additional Advanced Pharmaceutical Intermediate with Fermion	Dec. 14	CI
Ami Organics Limited Unveils New Manufacturing Facility in Ankleshwar, Gujarat	Dec. 14	CI
CARE Gives A Rating to Ami Organics' Long-term Bank Financing; Outlook Stable	Nov. 23	MT
Transcript : Ami Organics Limited, Q2 2024 Earnings Call, Nov 09, 2023	Nov. 09
Ami Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 08	CI
Ami Organics Limited announced that it has received INR 518.4515 million in funding	23-09-24	CI
Ami Organics to Supply Advanced Pharmaceutical Intermediates to Unit of Finland-based Orion	23-09-15	MT
Ami Organics Limited Signs Definitive Multi-Year Multi-Tonne Agreement with Fermion	23-09-15	CI
Ami Organics Forms New Wholly Owned Arm	23-09-14	MT
Ami Organics Limited Announces Incorporation of Wholly Owned Subsidiary	23-09-14	CI
INDIA STOCKS-Financials, IT lead rise in Indian shares as U.S. rate concerns ease	23-08-30	RE
Indian shares set to open higher on easing US rate concerns	23-08-29	RE
Transcript : Ami Organics Limited, Q1 2024 Earnings Call, Aug 11, 2023	23-08-11
Ami Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-11	CI
Ami Organics Limited Approves Incorporation of the Wholly Owned Subsidiary Company	23-08-04	CI
Ami Organics Limited Announces Appointment of Mr. Nareshkumar R. Patel as Member and Chairman of the Risk Management Committee	23-08-04	CI
Transcript : Ami Organics Limited, Q4 2023 Earnings Call, May 15, 2023	23-05-15
Ami Organics Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-13	CI
Ami Organics Limited Recommends Final Dividend for the Year 2022-23	23-05-13	CI

Ami Organics Limited is an India-based manufacturer of specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). It manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. It has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The Company supplies its products to more than 150 customers directly in India and to approximately 25 countries overseas.

Sector

Diversified Chemicals

Calendar

2024-05-12 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Ami Organics Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,214 INR

Average target price

1,298 INR

Spread / Average Target

+6.91%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

	1st Jan change	Capi.
AMI ORGANICS LIMITED	+8.21%	541M
SHIN-ETSU CHEMICAL CO., LTD.	-0.19%	80.96B
BASF SE	+0.09%	48.75B
DUPONT DE NEMOURS, INC.	-3.82%	30.73B
PIDILITE INDUSTRIES LIMITED	+9.85%	17.82B
BRENNTAG SE	-10.05%	11.7B
SYENSQO SA/NV	-8.09%	9.65B
ASAHI KASEI CORPORATION	+2.79%	9.52B
SRF LIMITED	+6.35%	9.39B
MITSUBISHI CHEMICAL GROUP CORPORATION	+3.85%	8.2B

Diversified Chemicals